MX9304399A - Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados. - Google Patents

Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.

Info

Publication number
MX9304399A
MX9304399A MX9304399A MX9304399A MX9304399A MX 9304399 A MX9304399 A MX 9304399A MX 9304399 A MX9304399 A MX 9304399A MX 9304399 A MX9304399 A MX 9304399A MX 9304399 A MX9304399 A MX 9304399A
Authority
MX
Mexico
Prior art keywords
prepare
bromoethyl
imidazol
nitro
amino
Prior art date
Application number
MX9304399A
Other languages
English (en)
Inventor
Gerald Edward Adams
Edward Martin Fielden
Matthew Alexander Naylor
Ian James Stratford
Vladimir Genukh Beylin
Anthony Denver Sercel
Howard Daniel Holli Schowalter
Original Assignee
Warner Lambert Co
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, British Tech Group filed Critical Warner Lambert Co
Publication of MX9304399A publication Critical patent/MX9304399A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describen los compuestos quirales útiles como radiosensibilizadores o quimiosensibilizadores que tiene la fórmula: en donde X es halógeno, los intermediarios usados para preparar estos compuestos y un proceso novedoso para preparar estos compuestos.
MX9304399A 1992-07-31 1993-07-21 Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados. MX9304399A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92320992A 1992-07-31 1992-07-31

Publications (1)

Publication Number Publication Date
MX9304399A true MX9304399A (es) 1994-02-28

Family

ID=25448313

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304399A MX9304399A (es) 1992-07-31 1993-07-21 Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.

Country Status (12)

Country Link
US (4) US5342959A (es)
EP (1) EP0652870A1 (es)
JP (1) JPH07509489A (es)
KR (1) KR950702537A (es)
AU (1) AU4784293A (es)
CA (1) CA2136328A1 (es)
CZ (1) CZ10395A3 (es)
FI (1) FI950383A0 (es)
HU (1) HUT71347A (es)
MX (1) MX9304399A (es)
SK (1) SK8495A3 (es)
WO (1) WO1994015922A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5965621A (en) * 1995-08-17 1999-10-12 Allergan Methods and compositions for reducing or maintaining body weight in a mammal
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US20040191843A1 (en) * 2003-02-03 2004-09-30 Palo Alto Institute Of Molecular Medicine Cell-killing molecules and methods of use thereof
CN1314396C (zh) * 2005-04-28 2007-05-09 南京圣和药业有限公司 左旋奥硝唑在制备抗厌氧菌感染药物的应用
CN1332662C (zh) * 2005-04-29 2007-08-22 南京圣和药业有限公司 左旋奥硝唑的静脉给药制剂及其制备方法
CN1305469C (zh) * 2005-07-08 2007-03-21 南京圣和药业有限公司 左旋奥硝唑在制备抗寄生虫感染的药物中的应用
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
CN100368402C (zh) * 2005-11-16 2008-02-13 沈阳中海生物技术开发有限公司 奥硝唑光学对映体的制备方法
CN112774569B (zh) * 2021-01-11 2022-04-08 江门市华熊新材料有限公司 含氟咪唑表面活性剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
EP0095906B1 (en) * 1982-05-27 1986-10-22 National Research Development Corporation Improvements relating to compounds useful in radiotherapy or chemotherapy
US4946496A (en) * 1982-06-01 1990-08-07 E. I. Du Pont De Nemours And Company Herbicidal diazoles
US5098921A (en) * 1987-12-04 1992-03-24 National Research Development Corporation Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
MX9304399A (es) * 1992-07-31 1994-02-28 Warner Lambert Co Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.

Also Published As

Publication number Publication date
HUT71347A (en) 1995-11-28
SK8495A3 (en) 1995-08-09
US5543527A (en) 1996-08-06
FI950383A7 (fi) 1995-01-27
AU4784293A (en) 1994-08-15
US5659048A (en) 1997-08-19
US5481000A (en) 1996-01-02
CA2136328A1 (en) 1994-07-21
KR950702537A (ko) 1995-07-29
US5342959A (en) 1994-08-30
CZ10395A3 (en) 1995-11-15
HU9500269D0 (en) 1995-03-28
FI950383A0 (fi) 1995-01-27
WO1994015922A1 (en) 1994-07-21
EP0652870A1 (en) 1995-05-17
JPH07509489A (ja) 1995-10-19

Similar Documents

Publication Publication Date Title
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
ES2059317T3 (es) Tolunitrilos alfa-heterociclo-sustituidos.
MX9205573A (es) Nuevas 9-amino-7-(amino substituido)-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composicion farmaceutica que las contiene
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
PY0101650A (es) 2-phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethyla-mine derivatives
MX9204327A (es) Beta-lactamas substituidas compuestos utiles como agentes hipocolesteromicos y procedimientos para preparar los mismos.
MX9205532A (es) Nuevas 7-sustituidas-9-amino sustituidas 6-desmetil-6-desoxitetraciclinas, metodo para su producciony composicion farmaceutica que las contiene.
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
ATE233274T1 (de) Oxyiminopregnancarbolactone
FI834872A0 (fi) Substituerade 4-aminoetylen-kromaner och -kromener, foerfaranden foer deras framstaellning och deraanvaendning som laekemedel
MX9205678A (es) Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.
EA199900279A1 (ru) Производные бензамида и их применение в качестве лекарственных средств с лтв4-антагонистической активностью
ES2150808T3 (es) Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
ES477520A1 (es) Procedimiento para la preparacion de nuevas penicilinas.
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
ES2184774T3 (es) Bifenil-2,2'-diil-bis-difenilfosfinas halogenadas, su preparacion y empleo.
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
ES2060127T3 (es) Halogenoalquilfenil-alcoholes-cetonas y sus hidratos.
PT80791B (pt) Processo para a preparacao de novas fenil-naftiridinas uteis nomeadamente como medicamentos anti-ulcerosos
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
ES2063224T3 (es) Benzoxacinil-pirazoles, su produccion y su uso.